Raj Atikkuke, a molecular medicine and genetics researcher and founder of ITOS Oncology, speaks to reporters following a media event discussing the latest cancer research technology at Hotel-Dieu Grace Healthcare, July 5, 2017. Dax Melmer / Windsor Star
Bladder cancer progresses quickly in some patients but not in others. Why? The answer is probably in the cancer cell genes.
Somewhere in each cancer cell are genes that have mutated. If those genes and their mutations can be identified, they can be targeted with treatment that is more effective and has fewer side-effects.
Its personalized cancer treatment.
This is the future of cancer diagnosis, of cancer treatment, of cancer management, of cancer prognosis, molecular medicine and genetics researcher Raj Atikkuke said Wednesday, surrounded by local oncologists and other researchers as he launched his company ITOS Oncology at Hotel-Dieu Grace Healthcare.
Raj Atikkuke, a molecular medicine and genetics researcher and founder of ITOS Oncology, speaks to reporters following a media event discussing the latest cancer research technology at Hotel-Dieu Grace Healthcare, July 5, 2017. Dax Melmer / Windsor Star
Atikkuke and others hope that Windsor, where the rate of new cancer cases and cancer mortality are higher than the rest of Ontario, can become a leader in the rapid transformation of care.
It might be that we develop one profile that works really well in one disease site and everybody in the world sends it to us, said Dr. Caroline Hamm, clinical director of the Windsor Cancer Research Group. Were looking for what we can do better than anybody else and be the centre of cancer therapy for that particular disease.
Cancer is caused by mutations in key genes, called oncogenes. So every cancer can be defined by its genomic profile. Cancer drugs are most effective when they target the oncogene mutations. For example, there is a specific mutation that occurs in one gene in melanoma, a deadly skin cancer. A drug has been developed that targets that mutation and is known to work best in those patients.
ITOS, which stands for Its The Oncogene Signature, extracts DNA from cancer cells and searches for signature genetic mutations.
When we have that information, it becomes easier to target those cancer cells, said Atikkuke, who is collaborating with the University of Windsor and Windsor Regional Cancer Centre.
Researchers can also look for mutations in genes that make people susceptible to cancer. For example, there are a number of inherited genetic mutations that predispose women to breast cancer,
ITOS is the only centre in Ontario west of London that sequences cancer genes and one of few in North America that will provide a complete genetic profile of a cancer.
Ontario pays for testing for a limited number of proven genetic markers in certain cancers, such as lung cancer. But the testing isnt done here. Samples are sent to London, Hamilton and Toronto. The government also pays for a fuller genetic profile of breast cancers. That testing is done in California. The information sent back from across Ontario and California tells doctors what treatment is likely to work best. Performing a genetic profile of a cancer at ITOS will cost about $1,000. Research is expected to be paid for by grants.
Eventually, every cancer patient is expected to receive a genetic profile. It will save money, said Atikkuke. Now, most patients require a cocktail of chemotherapy drugs. In the future, theyll need only one, targeted drug.
Its important for Windsor, which has a burgeoning health care research sector, to do this kind of work, said Hamm.
Were very far away from things in Ontario. There are people that forego therapy because of the travel. Their families cant take them. Theyre not healthy enough to travel. We have to realize that we have a unique need here. We need to develop our clinical and research facilities here because if we dont, patient outcomes will be compromised.
ITOS will do laboratory research first here, said Hamm. Windsor has archived tissue and data bases with information on thousands of local cancer patients what stage cancer they had, what chemotherapy they received, how long they lived. Beginning with a subset of patients, for example those with a certain type of breast cancer, researchers can study the genetic profiles of the cancers.
We can see, Oh, this is why that group of people didnt do as well as the other group, said Hamm. Because they have this pattern on their genetic profile. This pattern is a group we need to focus on. Is there something in this pattern that we can target? If we did this a little bit differently, maybe we could have more people live. Thats what its about.
Clinical trials could be conducted eventually, the data could be published, and if the world says yes, that is valid data, everyone with that type of cancer will send their tissue to ITOS Oncology and say we need this tested.
There are many steps, she acknowledged, but this is where it starts.
Atikkuke will also travel to India this month to try to get hospitals and cancer centres there to send their patients DNA here for testing.
The difficult thing about treating cancer, said Hamm, is it isnt all one disease, as genetic profiling has shown. Advances in treatment have been unbelievable, she said. The ability to target treatment means some patients have been cured without chemotherapy or can live normal lifespans despite having cancer and receiving treatment.
Thats the beauty of targeted therapy, she said. Its not just, Lets kill everything and hope healthy stuff grows back.'
But, referring to ITOS, she said, this is the stuff we need to continue moving it forward.
Twitter.com/winstarjarvis
Originally posted here:
Jarvis: New Windsor company aims to personalize cancer treatment ... - Windsor Star
- Podcast 9 Athens part 3 and news - November 8th, 2009 [November 8th, 2009]
- Podcast 10 Athens part 4 - November 8th, 2009 [November 8th, 2009]
- Podcast 11 Athens Part 5 - November 8th, 2009 [November 8th, 2009]
- Episode 12 Cardiac Nuclear Medicine in the UK - November 8th, 2009 [November 8th, 2009]
- Podcast 13 Choline PET and prostate cancer - November 8th, 2009 [November 8th, 2009]
- Episode14 ED function and Dysponea - November 8th, 2009 [November 8th, 2009]
- ep 15 Collimator Choice and Reconstruction algorithm - November 8th, 2009 [November 8th, 2009]
- Episode 16 Dr Strauss on vulnerable plaque - November 8th, 2009 [November 8th, 2009]
- Episode17 Chemical Stress - November 8th, 2009 [November 8th, 2009]
- Episode 18 Myocardial Perfusion Imaging and Diabetes - November 8th, 2009 [November 8th, 2009]
- Episode 19 The INSPIRE trial - November 8th, 2009 [November 8th, 2009]
- 20 Dual isotope with a difference - November 8th, 2009 [November 8th, 2009]
- Episode 21 The real effect of stress - November 8th, 2009 [November 8th, 2009]
- Episode 22 D-SPECT - November 8th, 2009 [November 8th, 2009]
- Episode 23 VQ Reprise - November 8th, 2009 [November 8th, 2009]
- Episode 24 Hepatobiliary Nuclear Medicine - November 8th, 2009 [November 8th, 2009]
- Episode 25 Sleep Apnea - November 8th, 2009 [November 8th, 2009]
- Episode 26 Imaging Post Traumatic Stress Disorder - November 8th, 2009 [November 8th, 2009]
- Episode 27 Cardiac Stem Cells - November 8th, 2009 [November 8th, 2009]
- Episode 28 Molly Supply - November 8th, 2009 [November 8th, 2009]
- Episode 29 Melanoma therapy interview with Dr Ekaterina Dadachova - November 8th, 2009 [November 8th, 2009]
- Episode 30 Viral Therapy - November 8th, 2009 [November 8th, 2009]
- Episode 31 breast radiotherapy using radioisotopes - November 8th, 2009 [November 8th, 2009]
- Episode 32 news from snm - November 8th, 2009 [November 8th, 2009]
- Episode 33 EBV Imaging and Therapy - November 8th, 2009 [November 8th, 2009]
- Episode 34 Dr Lele SNM India 2009 - December 14th, 2009 [December 14th, 2009]
- Episode 35 Dr Andrew Scott from the Ludwig institute - January 10th, 2010 [January 10th, 2010]
- Episode 36 CardiArc - February 25th, 2010 [February 25th, 2010]
- Episode 37 Dr Modder Radiosynoviorthesis (Radiation Synovectomy) - March 31st, 2010 [March 31st, 2010]
- Episode 38 Indian Nuclear Medicine With Dr Malhotra and Dr Krishna - May 28th, 2010 [May 28th, 2010]
- Episode 39 Prof Ora Israel The Utility of Hybrid Imaging - July 13th, 2010 [July 13th, 2010]
- Episode 40 New V/Q SPECT developments - October 11th, 2010 [October 11th, 2010]
- Episode 41 scintimun - February 14th, 2011 [February 14th, 2011]
- Episode 42 Radio-Isotope Supply into the future - March 6th, 2011 [March 6th, 2011]
- Podcast 4: DNA therapy - April 24th, 2011 [April 24th, 2011]
- Sorry about the delay a new podcast will be out soon! - April 24th, 2011 [April 24th, 2011]
- Podcast 5 Flash 3D - April 24th, 2011 [April 24th, 2011]
- Podcast 6 Affibody - April 24th, 2011 [April 24th, 2011]
- Podcast 7 EANM 2006 Athens Part 1 - April 24th, 2011 [April 24th, 2011]
- Podcast 8 Athens Part 2 - April 24th, 2011 [April 24th, 2011]
- Episode 43 Rapidscan Part 1, 720P high quality video version - May 1st, 2011 [May 1st, 2011]
- Episode 43 Rapidscan Part 1, Ipod quality video - May 1st, 2011 [May 1st, 2011]
- Episode 43 Rapidscan Part 1, Audio version - May 1st, 2011 [May 1st, 2011]
- Episode 45 Mummies with cardiovascular disease video - May 21st, 2011 [May 21st, 2011]
- Episode 45 Mummies with cardiovascular disease audio edition - May 21st, 2011 [May 21st, 2011]
- Episode 46 Dr Gordon DePuey Choosing Reconstruction clinical perspective - August 7th, 2011 [August 7th, 2011]
- Episode 46 Dr Gordon DePuey Choosing Reconstruction clinical perspective audio version - August 7th, 2011 [August 7th, 2011]
- Episode 47 Cardiac Image Fusion With Dr Kaufmann - September 18th, 2011 [September 18th, 2011]
- Episode 47 Cardiac Fusion with Dr Kaufmann video version - September 18th, 2011 [September 18th, 2011]
- Dear Steve, I am and many more like me are your one more thing. - October 9th, 2011 [October 9th, 2011]
- EPISODE 48 PET MRI camera from Siemens with Dr Georgi audio - October 23rd, 2011 [October 23rd, 2011]
- EPISODE 48 PET MRI camera from Siemens Dr Georgi video - October 23rd, 2011 [October 23rd, 2011]
- Silicon Biosystems to Present Single-Circulating Tumor Cell Molecular Characterization at the Fourth World CTC Summit - April 25th, 2012 [April 25th, 2012]
- Leukaemia cells have a remembrance of things past - April 25th, 2012 [April 25th, 2012]
- Technologist Education Requirements Can Help Cut Repeat Scans - April 25th, 2012 [April 25th, 2012]
- HKU Collaborative Research Discovers A Novel Molecular Mechanism Of A New Anti-HIV-1 Drug Candidate - April 25th, 2012 [April 25th, 2012]
- Focal Segmental Glomerulosclerosis and the Nephrotic Syndrome - Part 1 Clinical - Video - May 4th, 2012 [May 4th, 2012]
- Electro-Medicine : Biological Physics - The Molecular Basis of Alzheimers Disease - Video - May 4th, 2012 [May 4th, 2012]
- osdd heterocyclic compounds and molecular medicines - Video - May 4th, 2012 [May 4th, 2012]
- Molecule to Medicine: The Biomarker Frontier - Video - May 4th, 2012 [May 4th, 2012]
- Fulfilling the Promise of Molecular Medicine in a Developmental Brain Disorder - Video - May 4th, 2012 [May 4th, 2012]
- Focus on Stefanie Dimmeler - Video - May 4th, 2012 [May 4th, 2012]
- Dundee - May 4th, 2012 [May 4th, 2012]
- Nanotechnology In Medicine: Huge Potential, But What Are The Risks? - May 5th, 2012 [May 5th, 2012]
- Cutting Edge Technology Coming To DMH - May 5th, 2012 [May 5th, 2012]
- This Week in Experimental and Molecular Pathology - May 5th, 2012 [May 5th, 2012]
- Researchers' discovery offers hope for cancer, heart disease miracle drugs - May 7th, 2012 [May 7th, 2012]
- Penn State student Zachary Hostetler from Garnet Valley is being honored as a student marshal - May 7th, 2012 [May 7th, 2012]
- NCKU Student Wins Prestigious Award for Anti-Cancer Research - May 10th, 2012 [May 10th, 2012]
- In-Vitro Diagnostics (IVD) Market (Clinical Chemistry, Immunoassays, Molecular Diagnostics, Hematology Analyzers ... - May 10th, 2012 [May 10th, 2012]
- Pitt team uses genomics to identify a molecular-based treatment for a viral skin cancer - May 10th, 2012 [May 10th, 2012]
- Genomics used to identify a molecular-based treatment for a viral skin cancer - May 10th, 2012 [May 10th, 2012]
- 2 molecular biologists get $500K medical prize - May 13th, 2012 [May 13th, 2012]
- 2 molecular biologists share $500K medical prize - May 13th, 2012 [May 13th, 2012]
- Lab21 Unveils New Molecular Analysis Services at Greenville Site - May 13th, 2012 [May 13th, 2012]
- 2 molecular biologists from NYC to share $500K medical prize for pioneering research on cells - May 13th, 2012 [May 13th, 2012]
- Two Molecular Biologists Get $500K Medical Prize - May 13th, 2012 [May 13th, 2012]
- Pair of molecular biologists receive Albany Medical Center Prize - May 13th, 2012 [May 13th, 2012]
- CNIO scientists successfully test the first gene therapy against aging-associated decline - May 16th, 2012 [May 16th, 2012]
- Cancer Institute of New Jersey Aims to Advance Personalized Cancer Treatments Through 'Precision Medicine' - May 16th, 2012 [May 16th, 2012]